Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN) in a report released on Wednesday morning. The firm issued a sell rating on the biotechnology company’s stock.

Evogene Stock Performance

Shares of Evogene stock opened at $0.67 on Wednesday. Evogene has a 1 year low of $0.45 and a 1 year high of $1.44. The company has a market capitalization of $27.60 million, a P/E ratio of -1.26 and a beta of 1.49. The company’s fifty day moving average is $0.79 and its two-hundred day moving average is $0.74.

Evogene (NASDAQ:EVGN) last issued its quarterly earnings data on Thursday, March 7th. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.01. Evogene had a negative net margin of 423.39% and a negative return on equity of 76.93%. The company had revenue of $0.58 million for the quarter, compared to the consensus estimate of $1.73 million. During the same period last year, the firm posted ($0.07) EPS.

Institutional Trading of Evogene

An institutional investor recently raised its position in Evogene stock. Silverarc Capital Management LLC lifted its stake in Evogene Ltd. (NASDAQ:EVGN) by 3,000.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,100,000 shares of the biotechnology company’s stock after purchasing an additional 3,000,000 shares during the period. Silverarc Capital Management LLC owned approximately 7.52% of Evogene worth $1,818,000 as of its most recent SEC filing. Institutional investors and hedge funds own 10.40% of the company’s stock.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.